Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease

NCT05914818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-11-03

No results posted yet for this study

Summary

The goal of this clinical trial is to analyze the usability and safety of the prototype gait exoskeleton EXPLORE V2 in children with neurological and neuromuscular disease.

Participants will use the exoskeletons in their home and the community and variables regarding safety and usability will be measured and recorded.

Conditions

  • Cerebral Palsy
  • Acquired Brain Injury
  • Neuromuscular Diseases in Children

Interventions

DEVICE

EXPLORER V2

4 sessions of use of the exoskeleton, 1 in a laboratory of gait analysis and 3 in the home and the community of the participants

Sponsors & Collaborators

  • National Research Council, Spain

    collaborator OTHER_GOV
  • Hospital Infantil Universitario Niño Jesús, Madrid, Spain

    collaborator OTHER
  • Hospital Universitario La Paz

    collaborator OTHER
  • Hospital Universitario 12 de Octubre

    collaborator OTHER
  • Hospital General Universitario Gregorio Marañon

    collaborator OTHER
  • MarsiBionics

    lead INDUSTRY

Principal Investigators

  • Olga Arroyo Riaño · Hospital Universitario Gregorio Marañón

  • María Teresa Vara Arias · Hospital Infantil Universitario Niño Jesús

  • Ignacio Martínez Caballero · Hospital Infantil Universitario Niño Jesús

  • Sandra Espinosa García · Hospital Univsersitario La Paz

  • Sofía García de las Peñas · Hospital 12 de Octubre

  • Elena García Armada · National Research Council, Spain

  • Eva Barquín Santos · Marsi Bionics S L

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-23
Primary Completion
2023-09-29
Completion
2023-09-29

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05914818 on ClinicalTrials.gov